Search
for
Sort by
Research 511–540 of 1000+
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.
- Homoeopathic intervention in classic case of alopecia areata: A case study
- Brief Treatment Modalities of Alopecia Areata: Review Article
- Breast Implant-Associated Immunological Disorders
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Adult-onset Satoyoshi syndrome in a young male
- Celiac Disease: Beyond Diet and Food Awareness
- Pathophysiology of the Behçet's Disease
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Types and Treatment of Hair Loss in Men and Women
- RECENT DEVELOPMENTS IN ALOPECIAS
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Infliximab Induced Lupus in Crohnʼs Disease
- Alopecia: An OVerall Review Including Causes, COVID-19, Diet, And Treatments
- SUMMARIES OF PAPERS
- Skin disease in pregnancy
- European expert consensus statement on the systemic treatment of alopecia areata
- Clinical Response to Combined Therapy of Cyclosporine and Prednisone
- Rheumatologic Manifestations of Pregnancy
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Interstitial pneumonia with autoimmune features: challenges and controversies
- Th1 Chemokine CXCL10 and Alopecia Areata: The Possible Target for the Treatment of Alopecia Areata
- Immune-Mediated Diseases of the Central Nervous System
- HIV infection mimicking autoimmune disorder
- Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
- A case of pemphigus vulgaris developing after platelet-rich plasma treatment
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata